GTES reports Q2 EPS of $0.44 and revenue of $941.6M, exceeding estimates and prompting higher full-year guidance. Gates Industrial reported Q2 non-GAAP earnings per share of $0.44, topping estimates by $0.02, as revenue rose 6.6% year-over-year to $941.6M. The company also
Ken Griffin’s hedge fund purchased discounted public equities from the AI-focused fund following a 67% July loss. Citadel has acquired a significant portion of Situational Awareness’s public stock portfolio after the fund suffered heavy losses during July’s artificial inte
The utility firm exceeded Q2 profit and revenue forecasts, reaffirming its 2026 earnings guidance midpoint at $3.57 per share. Dominion Energy reported Q2 non-GAAP earnings of $0.79 per share, surpassing estimates by $0.11. Revenue reached $4.48 billion, up 17.6% year-over
2026 sees minimal consumer IPOs, with recent debuts underperforming amid a broader shift toward private funding. The IPO market has contracted sharply since 2021, when 743 companies listed on Nasdaq and raised nearly $500 billion. That year marked a record for new listings
Exxon Mobil reports $14.7B in Q2 adjusted earnings, missing analyst expectations despite a 67% quarterly rise. Exxon Mobil posted its highest quarterly profit in four years, with Q2 adjusted earnings climbing 67% quarter-over-quarter to $14.7B. The result, however, fell sh
CL stock declines after Q2 organic sales rose just 2.4%, missing expectations due to soft North America performance. Colgate-Palmolive (CL) shares fell in early trading Friday after reporting second-quarter results. Revenue increased 4.9% year-over-year to $5.36 billion, w
Amadeus IT Group reports 1H revenue of €3.33B, with adjusted EBIT up 4.9% year-over-year at constant currency. Amadeus IT Group posted first-half revenue of €3.33 billion, up 2.3% year-over-year on a reported basis and 5.1% at constant currency. The travel technology firm
Amazon reports 20% sales growth to $200.6B and 43% operating income rise to $27.5B for Q2. Amazon shares jumped over 11% in premarket trading following a stronger-than-expected second-quarter earnings report. The company posted a 20% increase in sales to $200.6 billion, wh
Tenax Therapeutics reports Q2 GAAP EPS of -$0.35 Tenax Therapeutics reported a Q2 GAAP EPS of -$0.35, beating estimates by $0.01. The company's cash and cash equivalents stood at $118.0 million as of June 30, 2026. Proceeds of $13.4 million were generated during
Moderna reports Q2 GAAP EPS of -$1.97 and revenue of $145M, exceeding analyst expectations while maintaining full-year outlook. Moderna posted a Q2 GAAP loss per share of $1.97, beating estimates by $0.09, as revenue rose 2.1% year-over-year to $145M, surpassing forecasts
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.